Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2008

Open Access 01-12-2008 | Research

Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity

Published in: Health and Quality of Life Outcomes | Issue 1/2008

Login to get access

Abstract

Background

Ulcerative colitis disease activity is determined by measuring symptoms and signs. Our aim was to determine which symptom domains are frequent and responsive to change in the evaluation of disease activity, which are those defined by three criteria: 1) they occur frequently during flares; 2) they improve during effective therapy for ulcerative colitis; and 3) they resolve during remission.

Methods

Twenty-eight symptom domains, 16 from standard indices and 12 novel domains identified by ulcerative colitis patient focus groups, were evaluated. Sixty subjects with ulcerative colitis were surveyed, rating each symptom on the three criteria with a 100 mm Visual Analogue Scale. Frequent and responsive symptoms were defined a priori as those whose median Visual Analogue Scale rating for all 3 criteria was significantly greater than 50.

Results

Thirteen of the 28 symptom domains were identified as both frequent in ulcerative colitis flares and responsive to changes in disease activity. Seven of these 13 symptom domains were novel symptoms derived from ulcerative colitis patient focus groups including stool mucus, tenesmus, fatigue, rapid postprandial bowel movements, and inability to differentiate liquid or gas from solid stool when rectal urgency occurs. Ten of the 16 symptom domains from standard indices were either infrequent or unresponsive to changes in disease activity.

Conclusion

Only some of the symptoms of ulcerative colitis that are important to patients are included in standard indices, and several symptoms currently measured are not frequent or responsive to change in ulcerative colitis patients. Development of survey measures of these symptom domains could significantly improve the assessment of disease activity in ulcerative colitis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6):1504–17. 10.1053/j.gastro.2004.01.063CrossRefPubMed Loftus EV Jr: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004, 126(6):1504–17. 10.1053/j.gastro.2004.01.063CrossRefPubMed
2.
go back to reference Langholz E, et al.: Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994, 107(1):3–11.PubMed Langholz E, et al.: Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994, 107(1):3–11.PubMed
3.
go back to reference Jess T, et al.: Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007, 13(4):481–9. 10.1002/ibd.20036CrossRefPubMed Jess T, et al.: Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis 2007, 13(4):481–9. 10.1002/ibd.20036CrossRefPubMed
4.
go back to reference Hoie O, et al.: Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007, 132(2):507–15. 10.1053/j.gastro.2006.11.015CrossRefPubMed Hoie O, et al.: Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007, 132(2):507–15. 10.1053/j.gastro.2006.11.015CrossRefPubMed
5.
go back to reference Nguyen GC, et al.: Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 2006, 4(12):1507–1513. 10.1016/j.cgh.2006.09.026CrossRefPubMed Nguyen GC, et al.: Racial and geographic variations in colectomy rates among hospitalized ulcerative colitis patients. Clin Gastroenterol Hepatol 2006, 4(12):1507–1513. 10.1016/j.cgh.2006.09.026CrossRefPubMed
6.
go back to reference Leijonmarck CE, Persson PG, Hellers G: Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990, 31(3):329–33. 10.1136/gut.31.3.329PubMedCentralCrossRefPubMed Leijonmarck CE, Persson PG, Hellers G: Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990, 31(3):329–33. 10.1136/gut.31.3.329PubMedCentralCrossRefPubMed
7.
go back to reference Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317(26):1625–9.CrossRefPubMed Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987, 317(26):1625–9.CrossRefPubMed
8.
go back to reference Sutherland LR, et al.: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987, 92(6):1894–8.PubMed Sutherland LR, et al.: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987, 92(6):1894–8.PubMed
9.
go back to reference D'Haens G, et al.: A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132(2):763–86. 10.1053/j.gastro.2006.12.038CrossRefPubMed D'Haens G, et al.: A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132(2):763–86. 10.1053/j.gastro.2006.12.038CrossRefPubMed
10.
go back to reference Seo M, et al.: An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992, 87(8):971–6.PubMed Seo M, et al.: An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992, 87(8):971–6.PubMed
11.
go back to reference Feagan BG, et al.: Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005, 352(24):2499–507. 10.1056/NEJMoa042982CrossRefPubMed Feagan BG, et al.: Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med 2005, 352(24):2499–507. 10.1056/NEJMoa042982CrossRefPubMed
13.
go back to reference Powell-Tuck J, Bown RL, Lennard-Jones JE: A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978, 13(7):833–7.CrossRefPubMed Powell-Tuck J, Bown RL, Lennard-Jones JE: A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978, 13(7):833–7.CrossRefPubMed
14.
go back to reference Stange EF, et al.: European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis 2008, 2(1):1–23. 10.1016/j.crohns.2007.11.001CrossRefPubMed Stange EF, et al.: European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis 2008, 2(1):1–23. 10.1016/j.crohns.2007.11.001CrossRefPubMed
15.
go back to reference Waljee A, et al.: Do Currently Available Disease Activity Indices Measure the Symptoms that Ulcerative Colitis Patients Experience During A Flare? Gastroenterology 2007, 132(4):44. (A191) 10.1053/S0016-5085(07)00536-7CrossRef Waljee A, et al.: Do Currently Available Disease Activity Indices Measure the Symptoms that Ulcerative Colitis Patients Experience During A Flare? Gastroenterology 2007, 132(4):44. (A191) 10.1053/S0016-5085(07)00536-7CrossRef
16.
go back to reference Minderhoud IM, et al.: IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004, 49(3):469–74. 10.1023/B:DDAS.0000020506.84248.f9CrossRefPubMed Minderhoud IM, et al.: IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004, 49(3):469–74. 10.1023/B:DDAS.0000020506.84248.f9CrossRefPubMed
Metadata
Title
Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity
Publication date
01-12-2008
Published in
Health and Quality of Life Outcomes / Issue 1/2008
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-6-69

Other articles of this Issue 1/2008

Health and Quality of Life Outcomes 1/2008 Go to the issue